Barrage Khalil 4

4 · Protagenic Therapeutics, Inc.\new · Filed May 5, 2021

Form 4

Period: 2021-05-03

Director

Transactions

Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.25/sh+45,000$56,250→ 95,000 total
Exercise/Conversion
PTIX Common stock Options
2021-05-03−150,000→ 165,000 total
Exercise: $1.25Exp: 2027-01-01→ PTIX common stock, Par Value $0.000001 (150,000 underlying)
Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.75/sh+45,000$78,750→ 290,000 total
Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.75/sh+120,000$210,000→ 410,000 total
Exercise/Conversion
Protagenic Therapeutics, Inc. Common Stock
2021-05-03$1.25/sh+150,000$187,500→ 245,000 total
Exercise/Conversion
PTIX Common stock Options
2021-05-03−45,000→ 120,000 total
Exercise: $1.75Exp: 2027-10-16→ PTIX common stock, Par Value $0.000001 (45,000 underlying)
Exercise/Conversion
PTIX Common stock Options
2021-05-03−120,000→ 0 total
Exercise: $1.75Exp: 2030-02-13→ PTIX common stock, Par Value $0.000001 (120,000 underlying)
Exercise/Conversion
PTIX Common stock Options
2021-05-03−45,000→ 315,000 total
Exercise: $1.25Exp: 2026-04-15→ PTIX common stock, Par Value $0.000001 (45,000 underlying)

Footnotes (3)

[F1]$532,500.00 was paid in cash by the reporting person as consideration for the aggregate option exercise.
[F2]Represents a cash exercise of stock options in which the reporting person paid the exercise price of such options in cash. No shares were sold by the reporting person in connection with this transaction.
[F3]The options are fully vested.

Documents

3 files